CEPI is providing US$4.5 million to non-profit Fondazione Biotecnopolo di Siena (FBS) for proof-of-concept research that will explore whether producing antigens in C1 filamentous fungus—applying ...

Dyadic International (NASDAQ:DYAI – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings ...

(“Dyadic”, “we”, “us”, “our ... protein—which involves extensive testing. In contrast, a C1 fungus cell line could be used to rapidly produce a pool of cells that generate ...

("Dyadic”, "we”, "us”, "our”, or the "Company”) (NASDAQ ... cell line-cells engineered to consistently produce the target vaccine protein-which involves extensive testing. In contrast, a C1 fungus ...

Dyadic’s microbial gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila). Our ...

Dyadic International ( ($DYAI) ) has shared an announcement. On March 20, 2025, Dyadic International announced a $4.5 million funding award from ...

World AGRI-Tech Innovation Summit March 11-12, 2025 San Francisco, CA Future Food-Tech March 13–14, 2025 San Francisco, CA Dyadic Booth No: #2 Microbial Engineering III: New Generation of Cell ...

JUPITER, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a ...

Dyadic's microbial gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila). Our ...

CTA Reporting Restored: FinCEN Extends Filing Deadlines and Signals Revisions to Reporting Requirements After Federal Court Lifts Stay ...